Lisofylline (racemic) | Anti-diabetic and Antiinflammatory agent
NMR (Conforms)
Available Options
| Size : | Price | Quantity | |
|---|---|---|---|
| 10 mg | $50.00 | ||
| 50 mg | $175.00 |
Lisofylline (6493-06-7, racemic) displays anti-inflammatory activity. Regulates immune cell function and autoimmune response by inhibition of IL-12 signalling and cytokine production.1 Protects pancreatic beta cells and prevents type I diabetes in non-obese diabetic mice.2 Lisofylline reduces LPS-induced TNF alpha levels in CD-1 mice.3 Cell permeable.
References/Citations:
1) Yang et al. (2005), Lisofylline: a potential lead for the treatment of diabetes; Biochem. Pharmacol., 69 1
2) Yang et al. (2002), The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice; Diabetologia, 45 1307
3) Wyska et al. (2010), Pharmacokinetic-pharmacodynamic modeling of methylxanthine derivatives in mice challenged with high-dose lipopolysaccharide; Pharmacology, 85 264
NMR (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
Lisofylline (6493-06-7, racemic) displays anti-inflammatory activity. Regulates immune cell function and autoimmune response by inhibition of IL-12 signalling and cytokine production.1 Protects pancreatic beta cells and prevents type I diabetes in non-obese diabetic mice.2 Lisofylline reduces LPS-induced TNF alpha levels in CD-1 mice.3 Cell permeable.
References/Citations:
1) Yang et al. (2005), Lisofylline: a potential lead for the treatment of diabetes; Biochem. Pharmacol., 69 1
2) Yang et al. (2002), The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice; Diabetologia, 45 1307
3) Wyska et al. (2010), Pharmacokinetic-pharmacodynamic modeling of methylxanthine derivatives in mice challenged with high-dose lipopolysaccharide; Pharmacology, 85 264
Related products
-
A-769662 | AMPK activator
From $72.00CAS:844499-71-4Catalog Number:10-1171Activity:AMPK activatorChemical Name:4-Hydroxy-3-(2′-hydroxy-[1,1′-biphenyl]-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrileMolecular Weight:360.39Molecular Formula:C20H12N2O3SSolubility:Soluble in DMSO (up to 30 mg/ml) or in Ethanol (up to 5 mg/ml),Physical Properties:Beige solidPurity:98% by HPLC
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.Shipping Code:RT -
Ciglitazone | PPARgamma agonist
From $80.00CAS:74772-77-3Catalog Number:10-1047Activity:PPARγ agonistChemical Name:(±)-5-[4-(1-Methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dioneMolecular Weight:333.45Molecular Formula:C18H23NO3SSolubility:Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).Physical Properties:Tan solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.Shipping Code:RT -
Andrographolide | Induces mitochondrial-mediated apoptosis
From $34.00CAS:5508-58-7Catalog Number:10-1173Activity:Induces mitochondrial-mediated apoptosisMolecular Weight:350.45Molecular Formula:C20H30O6Solubility:Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 8 mg/ml).Physical Properties:Off-white solidPurity:98%
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 2 years from date of purchsae as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.Shipping Code:RT
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
